Co-Authors
This is a "connection" page, showing publications co-authored by FREDERICK LANG and GREGORY N FULLER.
Connection Strength
1.873
-
Collision tumor: Multinodular and vacuolating neuronal tumor with isocitrate dehydrogenase-mutant diffuse astrocytoma. Neuropathology. 2024 Feb 27.
Score: 0.240
-
Long term outcomes following surgery for pineal region tumors. J Neurooncol. 2022 Feb; 156(3):491-498.
Score: 0.208
-
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol. 2018 05 10; 36(14):1419-1427.
Score: 0.158
-
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol. 2017 05 01; 19(5):660-668.
Score: 0.149
-
Origin of chordoid glioma of the third ventricle. Arch Pathol Lab Med. 2006 Apr; 130(4):460-4.
Score: 0.069
-
Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16. Mol Cancer Ther. 2005 Mar; 4(3):343-9.
Score: 0.064
-
Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun. 2024 May 02; 15(1):3728.
Score: 0.061
-
Subependymomas of the fourth ventricle: To operate or not to operate? J Clin Neurosci. 2023 Dec; 118:147-152.
Score: 0.059
-
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol. 2003 Jul 01; 21(13):2508-18.
Score: 0.057
-
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst. 2003 May 07; 95(9):652-60.
Score: 0.057
-
Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies. Neuro Oncol. 2002 10; 4(4):268-77.
Score: 0.054
-
Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. Cells. 2021 10 01; 10(10).
Score: 0.051
-
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. JCI Insight. 2020 09 03; 5(17).
Score: 0.047
-
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial. Clin Cancer Res. 2020 07 15; 26(14):3565-3577.
Score: 0.046
-
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
Score: 0.046
-
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro Oncol. 2019 06 10; 21(6):775-785.
Score: 0.043
-
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clin Cancer Res. 2018 12 15; 24(24):6288-6299.
Score: 0.041
-
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. J Neurosurg. 2018 12 01; 129(6):1446-1455.
Score: 0.039
-
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. J Neurosci. 2015 Nov 11; 35(45):15097-112.
Score: 0.034
-
Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathol. 2015 Oct; 130(4):587-97.
Score: 0.033
-
Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014 Aug; 106(8).
Score: 0.031
-
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015 Mar 26; 34(13):1619-1628.
Score: 0.030
-
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013 Jul 01; 73(13):3913-26.
Score: 0.028
-
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest. 2013 Feb; 123(2):855-65.
Score: 0.028
-
REST regulates oncogenic properties of glioblastoma stem cells. Stem Cells. 2012 Mar; 30(3):405-14.
Score: 0.026
-
Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures. J Neurooncol. 2011 Nov; 105(2):241-51.
Score: 0.025
-
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011 Jan; 121(1):161-73.
Score: 0.024
-
Magnetic resonance imaging features of pilocytic astrocytoma of the brain mimicking high-grade gliomas. J Comput Assist Tomogr. 2010 Jul; 34(4):601-11.
Score: 0.023
-
Surgical management of lateral-ventricle metastases: report of 29 cases in a single-institution experience. J Neurosurg. 2010 May; 112(5):1046-55.
Score: 0.023
-
Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res. 2006 Dec; 4(12):915-26.
Score: 0.018
-
Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia. 2006 May; 8(5):419-28.
Score: 0.017
-
Cystic glioblastoma multiforme: survival outcomes in 22 cases. J Neurosurg. 2004 Jan; 100(1):61-7.
Score: 0.015
-
IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):13970-5.
Score: 0.015
-
Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery. 2002 Jul; 51(1):2-12; discussion 12-3.
Score: 0.013